Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of UGT2B4 protein | affects expression | 20106945
|
D000654 |
Amobarbital |
UGT2B4 protein results in increased glycosylation of Amobarbital | increases glycosylation | 15013842
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of UGT2B4 mRNA | decreases expression | 20106945
|
C043211 |
carvedilol |
UGT2B4 protein results in increased glucuronidation of carvedilol | increases glucuronidation | 14744946
|
D002635 |
Chenodeoxycholic Acid |
Chenodeoxycholic Acid results in increased expression of UGT2B4 mRNA | increases expression | 17058234
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of UGT2B4 mRNA | increases expression | 17851650
|
D016572 |
Cyclosporine |
Cyclosporine affects the expression of UGT2B4 mRNA | affects expression | 20106945
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of UGT2B4 mRNA | decreases expression | 16404146
|
D004391 |
Dust |
Dust results in increased expression of UGT2B4 mRNA | increases expression | 17805423
|
D004958 |
Estradiol |
Estradiol results in decreased expression of UGT2B4 mRNA | decreases expression | 20106945
|
D005204 |
Farnesol |
UGT2B4 protein results in increased glucuronidation of Farnesol | increases glucuronidation | 15320866
|
D011345 |
Fenofibrate |
Fenofibrate results in increased expression of UGT2B4 mRNA | increases expression | 17058234
|
D005480 |
Flurbiprofen |
UGT2B4 protein results in increased glucuronidation of Flurbiprofen | increases glucuronidation | 15843492
|
D005978 |
Glutathione |
Glutathione deficiency results in increased expression of UGT2B4 mRNA | increases expression | 15345336
|
D007052 |
Ibuprofen |
UGT2B4 protein results in increased glucuronidation of Ibuprofen | increases glucuronidation | 15843492
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of UGT2B4 mRNA | decreases expression | 16807920
|
D007660 |
Ketoprofen |
UGT2B4 protein results in increased glucuronidation of Ketoprofen | increases glucuronidation | 15843492
|
D009288 |
Naproxen |
UGT2B4 protein results in increased glucuronidation of Naproxen | increases glucuronidation | 15843492
|
C115070 |
SX 3030 |
UGT2B4 protein results in increased glycosylation of SX 3030 | increases glycosylation | 15013842
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of UGT2B4 mRNA | decreases expression | 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.76 | 11752688 15322242 14514962 |
MESH:D058186 |
Acute Kidney Injury |
|
Ibuprofen |
9.29 | 6375363 |
MESH:D058186 |
Acute Kidney Injury |
|
Naproxen |
9.29 | 7897758 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
10.06 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
10.06 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
10.06 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ibuprofen |
10.06 | 10697514 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.60 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Flurbiprofen |
4.99 | 10680582 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.46 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
Ibuprofen |
3.15 | 18351690 |
MESH:D000707 |
Anaphylaxis |
|
Ibuprofen |
5.16 | 9532969 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.87 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.99 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Glutathione |
3.02 | 18929414 16917939 19056591 19267885 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.96 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.71 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.71 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.62 | 14601052 |
MESH:D002545 |
Brain Ischemia |
|
Ibuprofen |
4.80 | 15837124 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.73 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.92 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.92 | 15634643 16322301 16935488 17426702 18695136 16595493 18628466 15692762 16264153 16826403 11325840 15993339 18234424 15994142 19526202 18382427 17369602 15567936 16096432 15136595 15668708 17983394 15939500 16115903 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.92 | 16675129 14630087 17261762 17289903 19861407 18497071 12948864 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.92 | 20435547 |
MESH:D002100 |
Cachexia |
|
Ibuprofen |
5.38 | 15141370 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.38 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.73 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.73 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.57 | 12619106 21507988 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.57 | 16234567 16023760 17876044 18059187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.57 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.12 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.54 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.54 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Glutathione |
7.54 | 17015178 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.32 | 16120746 18850075 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
carvedilol |
8.37 | 15476868 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
8.37 | 16364871 15811867 17329180 17974986 17308081 16242529 15476868 17924179 17131338 16612575 17519947 16109756 17928571 16455267 16651473 15505089 17382496 16731534 17007740 17351982 16269455 18627295 15792986 16278810 16952015 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
carvedilol |
6.48 | 19477965 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
6.48 | 16243910 17334414 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.37 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.37 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.08 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.85 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.07 | 12621046 8697196 15668235 16354765 15340226 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 20055451 10048152 15322242 |
MESH:D003550 |
Cystic Fibrosis |
|
Glutathione |
4.41 | 19747007 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.65 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.33 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
6.21 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.21 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.21 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.89 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.89 | 11462148 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Ibuprofen |
5.53 | 18446180 16133044 18450898 |
MESH:D050171 |
Dyslipidemias |
|
Fenofibrate |
4.36 | 16707586 |
MESH:D004487 |
Edema |
|
Ketoprofen |
7.14 | 7990266 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.14 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.82 | 18230668 16714409 15322242 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
12.28 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.28 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Fenofibrate |
12.28 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Ibuprofen |
15.12 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Naproxen |
15.12 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
15.12 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.08 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Ibuprofen |
4.88 | 11545620 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.99 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.95 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.77 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.37 | 11858732 |
MESH:D005334 |
Fever |
|
Ibuprofen |
4.50 | 16997862 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.50 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.19 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.19 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.13 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.29 | 17150277 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.51 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.47 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.29 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.29 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.42 | 14766674 16330681 18674790 18006777 16879835 17888722 16144979 17875725 16495754 12587719 16244372 16707910 16244371 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.29 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.82 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.34 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.25 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.81 | 16120746 12621046 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.95 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.33 | 18501091 15147373 17606976 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.67 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.96 | 8697196 15340226 16354765 18606429 16959395 |
MESH:D006973 |
Hypertension |
|
carvedilol |
8.60 | 16640825 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.60 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.60 | 18670907 18850075 |
MESH:D006984 |
Hypertrophy |
|
Ibuprofen |
4.89 | 16672835 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Ibuprofen |
5.75 | 16133044 |
MESH:D007249 |
Inflammation |
|
Flurbiprofen |
11.78 | 11099482 |
MESH:D007249 |
Inflammation |
|
Ibuprofen |
11.78 | 3291741 |
MESH:D007249 |
Inflammation |
|
Naproxen |
11.78 | 3291741 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.78 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.91 | 16393666 16627594 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.25 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.36 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.80 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.80 | 15369732 16775033 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.80 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.07 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.03 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.03 | 15610895 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.08 | 16085563 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.92 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.92 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Fenofibrate |
4.92 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.92 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Naproxen |
3.89 | 16867024 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
10.46 | 15890375 18177683 9163691 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
10.46 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Fenofibrate |
10.46 | 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.46 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
13.73 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
13.73 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Fenofibrate |
13.73 | 18253720 18775883 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
13.73 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
4.76 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.76 | 20464547 18816296 18520028 17053015 20869020 6695378 18569708 20135361 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.76 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.76 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.40 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.72 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.48 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
9.81 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.81 | 11408345 11807958 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ibuprofen |
9.81 | 10697514 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.40 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.28 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.02 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.71 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Naproxen |
4.82 | 18803445 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.42 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.12 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.70 | 17415656 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.91 | 19429709 15857846 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.95 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.21 | 16810080 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.92 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.13 | 11141357 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.65 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Ibuprofen |
4.90 | 6375363 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.68 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.36 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.04 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.04 | 16889571 15640375 |
MESH:D009410 |
Nerve Degeneration |
|
Ibuprofen |
4.32 | 10961664 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.18 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.18 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.22 | 15555623 |
MESH:D010003 |
Osteoarthritis |
|
Ibuprofen |
4.08 | 7009135 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.04 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.19 | 19401270 |
MESH:D010146 |
Pain |
|
Ibuprofen |
7.56 | 3291741 |
MESH:D010146 |
Pain |
|
Naproxen |
7.56 | 3291741 |
MESH:D010149 |
Pain, Postoperative |
|
Ibuprofen |
5.06 | 16678543 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ibuprofen |
3.46 | 12384795 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.17 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.08 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.08 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.47 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.14 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.11 | 11896295 11222880 11118676 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.80 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.90 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.90 | 18437689 15897917 16729912 16868541 16888761 15749863 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.90 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Flurbiprofen |
1.90 | 17409433 |
MESH:D011471 |
Prostatic Neoplasms |
|
Ibuprofen |
1.90 | 17409433 |
MESH:D011507 |
Proteinuria |
|
Ibuprofen |
4.54 | 6375363 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.20 | 16882103 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.13 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.75 | 18990726 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.91 | 17203757 17710206 15675481 18313854 16767912 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.16 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.70 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.19 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
9.19 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.19 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.48 | 17203757 15625365 16767912 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.55 | 20155912 2093021 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.82 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.30 | 17909728 16010429 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.60 | 19048282 |
MESH:D014376 |
Tuberculosis |
|
Chenodeoxycholic Acid |
4.98 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.03 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.03 | 17653716 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.90 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.51 | 12125929 |
MESH:D020301 |
Vasospasm, Intracranial |
|
Ibuprofen |
5.10 | 19057314 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.13 | 17678736 17638931 17334414 16364871 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.17 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.36 | 17120751 |